{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:17:30Z","timestamp":1779099450909,"version":"3.51.4"},"reference-count":41,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Serum amyloid A (SAA) is an acute-phase reactant that increases rapidly in response to inflammatory stimuli and infection, earlier and more markedly than conventional markers such as C-reactive protein (CRP). However, large-scale evidence of its clinical utility in bloodstream infections (BSIs) remains limited. This study aimed to evaluate the diagnostic and prognostic value of SAA in patients presenting to the emergency department (ED) with suspected infection. Methods: We retrospectively reviewed the electronic medical records of adult patients who underwent simultaneous SAA and blood culture (BC) testing at the ED of a tertiary referral hospital between January and December 2025. Initial laboratory data, including CRP, procalcitonin (PCT), white blood cell (WBC) count, and absolute neutrophil count (ANC), were collected, and BSI was defined as the isolation of pathogenic organisms in BC. Correlations and agreement between SAA and other markers were assessed, and the diagnostic performance of BSI was evaluated using receiver operating characteristic curves and the area under the curve (AUC). Survival outcomes were analyzed using the Kaplan\u2013Meier method. Results: Among the 3321 included patients, 379 patients (11.4%) had positive BCs. Median SAA levels were significantly higher in BSI patients than in non-BSI patients (202.0 vs. 71.0 mg\/L, p &lt; 0.001), with the highest levels observed in Gram-negative infections. SAA showed a strong correlation with CRP (rs = 0.884) and a moderate correlation with PCT (rs = 0.576). The AUC for BSI diagnosis was highest for PCT (0.789), followed by SAA (0.650). The SAA demonstrated high sensitivity (90.5%) but low specificity (26.9%). Higher SAA levels were significantly associated with increased mortality rates. Conclusions: In adult ED patients, SAA is significantly associated with BSI and mortality and is a sensitive biomarker for the early detection of BSIs. Although SAA alone showed inferior discriminative performance compared to PCT, it may serve as an adjunctive screening tool in the ED, particularly in settings where PCT availability is limited.<\/jats:p>","DOI":"10.3390\/diagnostics16101510","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:56:27Z","timestamp":1779094587000},"page":"1510","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Performance and Prognostic Value of Serum Amyloid A in Patients with Bloodstream Infection"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-8223","authenticated-orcid":false,"given":"Hyein","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu 42601, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-2808","authenticated-orcid":false,"given":"Sunggyun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu 42601, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-Phase Proteins and Other Systemic Responses to Inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.1982.tb22153.x","article-title":"Serum C-reactive protein levels in disease","volume":"389","author":"Morley","year":"1982","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sori\u0107 Hosman, I., Kos, I., and Lamot, L. (2020). Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.631299"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"lmaf054","DOI":"10.1093\/labmed\/lmaf054","article-title":"Evaluation of serum amyloid A as a biomarker for sepsis diagnosis compared with C-reactive protein, procalcitonin, and presepsin","volume":"57","author":"Kim","year":"2026","journal-title":"Lab. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Schuetz, P., Albrich, W., and Mueller, B. (2011). Procalcitonin for diagnosis of infection and guide to antibiotic decisions: Past, present and future. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-107"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/ice.2022.304","article-title":"SHEA\/IDSA\/APIC Practice Recommendation: Strategies to prevent healthcare-associated infections through hand hygiene: 2022 Update","volume":"44","author":"Glowicz","year":"2023","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1038\/s41598-023-30807-5","article-title":"Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19","volume":"13","author":"Kyriazopoulou","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_10","first-page":"e15019","article-title":"Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis","volume":"13","author":"Velissaris","year":"2021","journal-title":"Cureus"},{"key":"ref_11","unstructured":"McPherson, R.A., and Pincus, M.R. (2021). Specific proteins. Henry\u2019s Clinical Diagnosis and Management by Laboratory Methods, Elsevier. [24th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Huang, N., Chen, J., Wei, Y., Liu, Y., Yuan, K., Chen, J., He, M., and Liu, N. (2022). Multi-marker approach using C-reactive protein, procalcitonin, neutrophil CD64 index for the prognosis of sepsis in intensive care unit: A retrospective cohort study. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07650-6"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1186\/s40001-025-03324-6","article-title":"Recent advances in biomarkers for detection and diagnosis of sepsis and organ dysfunction: A comprehensive review","volume":"30","author":"Chen","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Nowak, J., Ssanyu, J.N., Namiiro, F., Mountford, N., Parducci, A., Domijan, K., Daly, M., O\u2019Brien, D., Barden, E., and Walshe, K. (2025). Diagnosis of neonatal and adult sepsis using a Serum Amyloid A lateral flow test. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0314702"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/JPM.2002.048","article-title":"Serum amyloid A protein in the early detection of late-onset bacterial sepsis in preterm infants","volume":"30","author":"Arnon","year":"2002","journal-title":"J. Perinat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.jp.7211682","article-title":"Serum amyloid A: An early and accurate marker of neonatal early-onset sepsis","volume":"27","author":"Arnon","year":"2007","journal-title":"J. Perinatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SLE.0000000000000067","article-title":"Admission levels of serum amyloid a and procalcitonin are more predictive of the diagnosis of acute appendicitis compared with C-reactive protein","volume":"24","author":"Abbas","year":"2014","journal-title":"Surg. Laparosc. Endosc. Percutan. Tech."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Stute, M., Kreysing, M., Zorn, M., Michl, P., and Gauss, A. (2024). Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021177"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3349\/ymj.2007.48.2.218","article-title":"Serum amyloid a as a useful indicator of disease activity in patients with ankylosing spondylitis","volume":"48","author":"Jung","year":"2007","journal-title":"Yonsei Med. J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chen, R., Ren, S., Tang, H., and Wu, Q. (2025). Diagnostic value of Serum Amyloid A (SAA) in HIV-associated pulmonary infections and its correlation with inflammatory markers. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-11425-0"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xu, S., Song, Z., Han, F., and Zhang, C. (2023). Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: A retrospective cohort study. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08329-2"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lamy, B., Darg\u00e8re, S., Arendrup, M.C., Parienti, J.-J., and Tattevin, P. (2016). How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00697"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.21037\/jlpm.2018.12.02","article-title":"Reducing exposure to broad-spectrum antibiotics for bloodstream infection","volume":"3","author":"VanEpps","year":"2018","journal-title":"J. Lab. Precis. Med."},{"key":"ref_24","unstructured":"Clinical and Laboratory Standards Institute (2022). Principles and Procedures for Blood Cultures, Clinical and Laboratory Standards Institute. [2nd ed.]. CLSI Guideline M47-ED2."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-11-011932","article-title":"Serum amyloid A is an innate immune opsonin for Gram-negative bacteria","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/285498a0","article-title":"Monokine-induced synthesis of serum amyloid A protein by hepatocytes","volume":"285","author":"Selinger","year":"1980","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4049\/jimmunol.124.2.495","article-title":"Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein","volume":"124","author":"Benson","year":"1980","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Chang, Y., Liu, Y., Zou, Y., and Ye, R.D. (2025). Recent Advances in Studies of Serum Amyloid A: Implications in Inflammation, Immunity and Tumor Metastasis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26030987"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2443.2005.00900.x","article-title":"Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression","volume":"10","author":"Hagihara","year":"2005","journal-title":"Genes Cells"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.15263\/jlmqa.2023.45.4.156","article-title":"Clinical Utility of the Serum Amyloid A Test for the Diagnosis of Bacterial Infections in Patients Visiting the Emergency Room","volume":"45","author":"Bae","year":"2023","journal-title":"Lab. Med. Qual. Assur."},{"key":"ref_31","first-page":"163","article-title":"Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis","volume":"89","author":"Mayer","year":"2002","journal-title":"Br. J. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A\u2014A review","volume":"24","author":"Sack","year":"2018","journal-title":"Mol. Med."},{"key":"ref_33","first-page":"58","article-title":"Serum amyloid A in the assessment of early inflammatory arthritis","volume":"27","author":"Cunnane","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/1354750X.2011.607189","article-title":"Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times","volume":"16","author":"Takata","year":"2011","journal-title":"Biomarkers"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e44197","DOI":"10.1097\/MD.0000000000044197","article-title":"Meta-analysis of serum amyloid A for the diagnosis of neonatal sepsis: A comprehensive evaluation of diagnostic accuracy and clinical utility","volume":"104","author":"Wang","year":"2025","journal-title":"Medicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21614\/chirurgia.2660","article-title":"Significance of Biomarkers in Early Diagnosis of Abdominal Sepsis","volume":"117","author":"Arbutina","year":"2022","journal-title":"Chirurgia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108787","DOI":"10.1016\/j.clim.2021.108787","article-title":"Serum amyloid A\u2014A prime candidate for identification of neonatal sepsis","volume":"229","author":"Quttineh","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jinf.2020.03.035","article-title":"Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis","volume":"80","author":"Li","year":"2020","journal-title":"J. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Filev, R., Lyubomirova, M., Bogov, B., Kalinov, K., Hristova, J., Svinarov, D., and Rostaing, L. (2024). IL-6 and SAA\u2014Strong Predictors for the Outcome in COVID-19 CKD Patients. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010311"},{"key":"ref_40","first-page":"11386","article-title":"Expressions of SAA, CRP, and FERR in different severities of COVID-19","volume":"24","author":"Liu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xie, M., Min, Z., Jiang, W., He, Z., and Xia, X. (2025). Prognostic value of multivariate logistic regression analysis and amyloid A lactate monitoring in patients with severe pneumonia-associated sepsis. BMC Pulm. Med., 25.","DOI":"10.1186\/s12890-025-03648-3"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1510\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:32:27Z","timestamp":1779096747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diagnostics16101510"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16101510","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}